Published in Arch Surg on March 01, 1999
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg (2002) 8.30
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut (2002) 4.01
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25
Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients. Ann Surg (2005) 2.58
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol (2009) 2.17
Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg (2003) 2.04
Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg (2001) 1.87
Surgical management of hilar cholangiocarcinoma. Ann Surg (2005) 1.80
A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg (2002) 1.79
One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg (2006) 1.64
Current surgical treatment for bile duct cancer. World J Gastroenterol (2007) 1.30
The diagnosis and treatment of cholangiocarcinoma. Dtsch Arztebl Int (2014) 1.25
Current and emerging therapies for the treatment of pancreatic cancer. Onco Targets Ther (2010) 1.21
Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma. J Am Coll Surg (2016) 1.10
Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) (2009) 1.06
Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB (Oxford) (2008) 1.05
Preoperative biliary drainage and surgical outcome. Ann Surg (1999) 1.04
Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma. Langenbecks Arch Surg (2009) 1.03
Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction. World J Surg (2009) 1.01
Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg (2008) 1.00
Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality. World J Surg (2014) 0.98
Liver resection for cancer. World J Gastroenterol (2001) 0.97
Cholangiocarcinoma: preoperative biliary drainage (Con). HPB (Oxford) (2008) 0.94
Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Dig Dis Sci (2010) 0.93
Cholangiocarcinoma and its management. Gut (2007) 0.93
Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol (2011) 0.92
Diagnosis and initial management of cholangiocarcinoma with obstructive jaundice. World J Gastroenterol (2008) 0.89
Effect of preoperative biliary drainage on malignant obstructive jaundice: a meta-analysis. World J Gastroenterol (2011) 0.89
Surgical resection for hilar cholangiocarcinoma: experience improves resectability. HPB (Oxford) (2011) 0.89
Hilar cholangiocarcinoma: diagnosis and staging. HPB (Oxford) (2005) 0.87
Update on the management of cholangiocarcinoma. Dig Dis (2014) 0.87
Resistant pathogens in biliary obstruction: importance of cultures to guide antibiotic therapy. HPB (Oxford) (2005) 0.86
Surgical management and outcome of bile duct injuries following cholecystectomy: a single-center experience. Langenbecks Arch Surg (2011) 0.86
Value of preoperative biliary drainage in a consecutive series of resectable periampullary lesions. From randomized studies to real medical practice. Langenbecks Arch Surg (2012) 0.86
Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients. World J Gastroenterol (2012) 0.85
Operable malignant jaundice: To stent or not to stent before the operation? World J Gastrointest Endosc (2010) 0.84
Advances in diagnosis and treatment of hilar cholangiocarcinoma -- a review. Med Sci Monit (2013) 0.84
The Clinical Usefulness of Simultaneous Placement of Double Endoscopic Nasobiliary Biliary Drainage. Clin Endosc (2015) 0.82
The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers. Int J Clin Oncol (2013) 0.80
Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy. World J Gastroenterol (2013) 0.80
The current standard of care in the periprocedural management of the patient with obstructive jaundice. Ann R Coll Surg Engl (2006) 0.80
High Rate of Organ/Space Surgical Site Infection After Hepatectomy with Preexisting Bilioenteric Anastomosis. World J Surg (2016) 0.78
Bismuth classification is associated with the requirement for multiple biliary drainage in preoperative patients with malignant perihilar biliary stricture. Surg Endosc (2014) 0.77
Preoperative biliary MRSA infection in patients undergoing hepatobiliary resection with cholangiojejunostomy: incidence, antibiotic treatment, and surgical outcome. World J Surg (2011) 0.75
Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review. World J Surg Oncol (2016) 0.75
The critically ill patient after hepatobiliary surgery. Crit Care (1999) 0.75
Role of ciprofloxacin in patients with cholestasis after endoscopic retrograde cholangiopancreatography. World J Gastroenterol (2007) 0.75
A case of methicillin-resistant Staphylococcus aureus infection following bile duct stenting. World J Gastroenterol (2005) 0.75
Current Status of Biliary Metal Stents. Clin Endosc (2016) 0.75
Endoscopic and Photodynamic Therapy of Cholangiocarcinoma. Visc Med (2016) 0.75
Management of Malignant Biliary Obstruction. Semin Intervent Radiol (2016) 0.75
A novel, validated risk score to predict surgical site infection after pancreaticoduodenectomy. HPB (Oxford) (2016) 0.75
Common controversies in management of biliary strictures. World J Gastroenterol (2017) 0.75
Current status of preoperative biliary drainage. J Gastroenterol (2015) 0.75
Best options for preoperative biliary drainage in patients with Klatskin tumors. Surg Endosc (2016) 0.75
The type of preoperative biliary drainage predicts short-term outcome after major hepatectomy. Langenbecks Arch Surg (2016) 0.75
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (1988) 13.42
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Is duodenitis a dyspeptic myth? Lancet (1977) 6.17
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg (1999) 4.26
Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet (1987) 4.18
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med (1988) 4.02
A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg (1978) 3.91
Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet (1988) 3.30
Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg (2000) 3.06
Segment-oriented hepatic resection in the management of malignant neoplasms of the liver. J Am Coll Surg (1998) 3.04
Prospective study of colorectal cancer in the west of Scotland: 10-year follow-up. Br J Surg (1990) 3.01
Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg (1998) 2.97
Management of the Mirizzi syndrome and the surgical implications of cholecystcholedochal fistula. Br J Surg (1990) 2.89
Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg (1998) 2.81
Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg (1984) 2.78
Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg (1999) 2.65
Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg (2000) 2.60
Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg (2001) 2.57
Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol (2000) 2.48
Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg (2000) 2.43
A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol (1976) 2.42
Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39
Recent advances in the management of cholangiocarcinomas. Semin Liver Dis (1994) 2.30
Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts. Lancet (1984) 2.28
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol (2008) 2.12
Cannulation of papilla of vater via fiber-duodenoscope. Assessment of retrograde cholangiopancreatography in 60 patients. Lancet (1972) 2.09
Percutaneous transhepatic drainage in obstructive jaundice: advantages and problems. Br J Surg (1982) 2.07
Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments. Ann Surg (1984) 2.06
Let marketplace regulate specialization. Minn Med (1993) 2.04
Drainage is unnecessary after elective liver resection. Am J Surg (1996) 2.03
One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch Surg (1994) 2.03
Management of 155 patients with benign liver tumours. Br J Surg (2001) 1.97
Per-operative cholangiography and post-cholecystectomy biliary strictures. Ann R Coll Surg Engl (1985) 1.95
Gallbladder cancer discovered during laparoscopic surgery. Potential for iatrogenic tumor dissemination. Arch Surg (1993) 1.94
Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg (1995) 1.91
High coincidence of Mirizzi syndrome and gallbladder carcinoma. Surgery (1997) 1.89
Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest (1995) 1.89
Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg (2000) 1.85
Useful stapling techniques in liver surgery. J Am Coll Surg (1997) 1.83
Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J (1989) 1.82
Outcome of radical surgery in hilar cholangiocarcinoma. Surgery (1990) 1.79
Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol (1999) 1.75
Carcinoma in choledochal cysts. Age-related incidence. Arch Surg (1983) 1.75
Results of hepatic resection for sarcoma metastatic to liver. Ann Surg (2001) 1.75
Letter: Glucagon therapy in acute pancreatitis. Br Med J (1974) 1.74
Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol (1993) 1.73
Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg (2001) 1.69
Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery (1997) 1.68
Diffuse glomerulonephritis associated with infected ventriculoatrial shunt. N Engl J Med (1968) 1.67
Gallbladder carcinoma. Eur J Surg Oncol (2007) 1.65
Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207). FASEB J (1999) 1.64
Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol (2003) 1.63
Improvements in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg (1993) 1.63
Hand-assisted laparoscopic liver resection: lessons from an initial experience. Arch Surg (2000) 1.60
Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem (2000) 1.59
A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer (2001) 1.57
A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies. J Gastrointest Surg (2000) 1.57
Duodenitis. Clin Gastroenterol (1978) 1.53
Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol (2000) 1.52
Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet (1990) 1.50
Aspiration cytology in breast cancer. Its relevance to diagnosis. Lancet (1975) 1.49
Malignant masquerade at the hilum of the liver. Br J Surg (1985) 1.48
Prune-belly syndrome. Clinical findings and survival. Am J Dis Child (1969) 1.44
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg (1999) 1.41
Gallbladder carcinoma discovered during laparoscopic cholecystectomy: aggressive reresection is beneficial. Cancer (1998) 1.40
Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg (1995) 1.40
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol (2009) 1.39